机构:[1]Pharmaceutical Department of the First Affiliated Hospital of Guangdong Pharmaceutical University, Clinical Pharmacy Department of Guangdong Pharmaceutical University, Guangzhou 510080, People’s Republic of China[2]Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, People’s Republic of China[3]Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, People’s Republic of China大德路总院内分泌科大德路总院内分泌科广东省中医院[4]Pharmacy Department, General Hospital of Chinese People’s Armed Police Forces, Beijing 100039, People’s Republic of China[5]The Affiliated Chencun Hospital of Shunde Hospital, Southern Medical University, Foshan 528313, People’s Republic of China
Post-traumatic stress disorder (PTSD) is the serious psychiatric disorder. Paeoniflorin (PF) produces the antidepressant-like properties. However, few studies are concerned about its anti-PTSD-like effects and mechanisms. To investigate these, the single prolonged stress (SPS) model was utilized. PTSD-like behavioral deficits in rats after exposure to SPS were improved by PF (10 and 20 mg/kg, i.p.), evidenced by blocking increased freezing time in contextual fear paradigm (CFP) and increased time and entries in open arms in elevated plus maze (EPM) test without affecting the locomotor activity in open field (OF) test. We also found that increased levels of corticosterone (Cort), corticotropin releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) after exposure to SPS were reversed by PF (10 and 20 mg/kg, i.p.) in serum, respectively. Moreover, the decreased levels of serotonin (5-HT) and 5-Hydroxyindoleacetic acid (5-HIAA) in prefrontal cortex and hippocampus were reversed by PF (10 and 20 mg/kg, i.p.), respectively. In summary, the anti-PTSD-like activities of PF were associated with the modulation of HPA axis and 5-HT system activation.
基金:
This study was supported by a grant from Natural
Science Foundation of Guangdong Province, China (No.
2017A030313448), National Natural Science Foundation of China (No.
81703731) and Project of Educational Commission of Guangdong
Province, China (No. 2016KQNCX086).
第一作者机构:[1]Pharmaceutical Department of the First Affiliated Hospital of Guangdong Pharmaceutical University, Clinical Pharmacy Department of Guangdong Pharmaceutical University, Guangzhou 510080, People’s Republic of China[2]Guangdong Provincial Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
Zhi-Kun Qiu,Jia-Li He,Xu Liu,et al.Anxiolytic-like effects of paeoniflorin in an animal model of post traumatic stress disorder[J].METABOLIC BRAIN DISEASE.2018,33(4):1175-1185.doi:10.1007/s11011-018-0216-4.
APA:
Zhi-Kun Qiu,Jia-Li He,Xu Liu,Jia Zeng,Wei Xiao...&Ji-Sheng Chen.(2018).Anxiolytic-like effects of paeoniflorin in an animal model of post traumatic stress disorder.METABOLIC BRAIN DISEASE,33,(4)
MLA:
Zhi-Kun Qiu,et al."Anxiolytic-like effects of paeoniflorin in an animal model of post traumatic stress disorder".METABOLIC BRAIN DISEASE 33..4(2018):1175-1185